Paid Clinical Trials Hattiesburg
Discover 29 paid clinical trials in Hattiesburg, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fianlimab & CemiplimabA Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT05800015
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
fianlimab
cemiplimab
Pemetrexed
Paclitaxel
Carboplatin
SonrotoclaxA Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
Sponsor:
BeiGene
Location:
Code:
NCT05952037
Conditions
Waldenstrom Macroglobulinemia
Waldenstrom's Macroglobulinemia Recurrent
Waldenstrom's Macroglobulinemia Refractory
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sonrotoclax
Zanubrutinib
LuspaterceptELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT05949684
Conditions
Myelodysplastic Syndromes
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luspatercept
Epoetin Alfa
ZanubrutinibObservational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
Sponsor:
BeiGene
Location:
Code:
NCT05640102
Conditions
Waldenstrom Macroglobulinemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Zanubrutinib
Venetoclax & ObinutuzumabStudy to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Sponsor:
AbbVie
Location:
Code:
NCT04895436
Conditions
Chronic Lymphocytic Leukemia (CLL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Venetoclax
Obinutuzumab
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Buccal Film vs. IV PalonosetronBuccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
Sponsor:
Xiamen LP Pharmaceutical Co., Ltd
Location:
Code:
NCT05199818
Conditions
Chemotherapy-induced Nausea and Vomiting
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Palonosetron HCl Buccal Film 0.5 mg
IV Palonosetron 0.25 mg
AmivantamabA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT05379595
Conditions
Advanced or Metastatic Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Amivantamab
Fluorouracil
Leucovorin
Oxaliplatin
Irinotecan
Iberdomide vs. LenalidomideA Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT05827016
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Iberdomide
Lenalidomide
JNJ-64042056A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Sponsor:
Janssen Pharmaceutica N.V., Belgium
Location:
Code:
NCT06544616
Conditions
Preclinical Alzheimer's Disease
Eligibility Criteria
Sex: All
Age: 55 - 70+
Healthy Volunteers: Not accepted
Interventions
JNJ-64042056
Placebo
Sonrotoclax & ZanubrutinibA Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma
Sponsor:
BeiGene
Location:
Code:
NCT06742996
Conditions
Mantle Cell Lymphoma
B Cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sonrotoclax
Zanubrutinib
Placebo